Market Closed -
OTC Markets
03:47:28 2024-04-24 pm EDT
5-day change
1st Jan Change
0.0005
USD
+25.00%
0.00%
0.00%
Sales 2022
0.02
Sales 2023
0.03
Capitalization
448K
Net income 2022
-
Net income 2023
-
EV / Sales 2022
30,165,231
x
Net Debt
2022
367K
Net Debt
2023
268K
EV / Sales 2023
25,075,337
x P/E ratio 2022
-0.07
x
P/E ratio 2023
-0.39
x
Employees
5
Yield 2022 *
-
Yield 2023
-
Free-Float
78.65%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Apr. 10
CI
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System
Feb. 22
CI
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System
Jan. 17
CI
BioAdaptives Inc. Announces the Development of PROTEINnMORETM
Dec. 14
CI
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
Nov. 16
CI
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 13
CI
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season
Nov. 09
CI
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement
23-10-10
CI
BioAdaptives, Inc. Commences Development of A New Supplement for Women?S Health
23-10-05
CI
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-11
CI
BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-12
CI
BioAdaptives, Inc. Announces the Appointment of David Allen to its Board of Directors
23-04-13
CI
BioAdaptives, Inc. Signs Non-Exclusive Marketing Agreement with World Wellness, LLC
23-04-06
CI
BioAdaptives, Inc. Announces the Appointment of Dr. Yaguang Liu to its Board of Directors
23-04-05
CI
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-31
CI
More news
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
Feb. 22
AQ
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Feb. 01
AQ
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System
Jan. 17
AQ
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
Jan. 04
AQ
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
Dec. 21
AQ
More press releases
1 day +25.00%
Current month -16.67%
1 month -16.67%
6 months -61.54%
More quotes
Managers
Title Age Since
Chief Executive Officer
83
18-03-14
Director of Finance/CFO
82
19-09-10
Chief Operating Officer
78
21-05-30
Members of the board
Title Age Since
Chief Executive Officer
83
18-03-14
Director of Finance/CFO
82
19-09-10
Chief Operating Officer
78
21-05-30
More insiders
Date
Price
Change
Volume
24-04-24
0.0005
+25.00%
13,781,832
24-04-23
0.0004
-20.00%
4,850,618
24-04-22
0.0005
-7.41%
4,951,005
24-04-19
0.00054
-10.00%
1,614,108
24-04-18
0.0006
+20.00%
21,422,911
Delayed Quote
OTC Markets, April 24, 2024 at 03:47 pm EDT
More quotes
BioAdaptives, Inc. investigates, markets, and distributes natural plant- and algal-based products that enhance health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. Its product line for humans includes PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven, and ProteinNMore. The Company also markets the Lung Flute and PrimiLungs products in its Lung Armor packaging, emphasizing the anti-viral properties of the nutraceutical and general respiratory health benefits from use of the device. Its animal products include Canine All-in-One and Equine All-in-One products for dogs and horses. Pluripain is a fast-acting, long-lasting all-natural pain relief formulation. MindnMemory is a nootropic formulation that enhances memory, focus, mental clarity and endurance.
More about the company
1st Jan change
Capi.
0.00% 493K +6.96% 7.59B +5.49% 5.93B -8.63% 3.66B -13.28% 3.38B -15.49% 1.16B +10.65% 979M -39.71% 922M -18.47% 861M -17.52% 800M
Special Foods & Wellbeing Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1